Arjun Vasant Balar

Biosketch / Results /

Arjun Vasant Balar, M.D.

Assistant Professor; Co-Leader Genitourinary Cancers Program
Department of Medicine (Medicine)

Clinical Addresses

160 E. 34TH STREET
8TH FLOOR
NEW YORK, NY 10016
Handicap Access: yes
Phone: 212-731-5820
Fax: 212-731-5545

« Back to Results

Medical Specialties

Medical Oncology

Medical Expertise

Testicular Cancer, Prostate Cancer, Bladder Cancer, Genitourinary Cancer, Kidney Cancer

Clinical Responsibilities

My expertise is solely in the research and treatment of genitourinary tumors including prostate, kidney, testicular and bladder (urothelial) cancers. As a board-certified medical oncologist and faculty member of the NYU Langone Medical Center and Member of the NYU Cancer Institute's Genitourinary Cancers Research Program, I collaborate closely with a multidisciplinary team of surgeons, pathologists, radiation oncologists, nurses, and social workers to provide the most sophisticated, up-to-date, and personalized care.

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, CIGNA EPO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, ELDERPLAN, FIDELIS CHLD HLTH, FIDELIS EXCHANGE, FIDELIS FAM HLTH, FIDELIS MEDICARE, Fidelis Medicaid, GHI CBP, HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, METROPLUS CHLD HLTH, METROPLUS EXCHANGE PLANS, METROPLUS FAM HLTH, MULTIPLAN/PHCS PPO, Medicare, MetroPlus Medicaid, NY MEDICAID OPT-OUT (OPRA), NYS EMPIRE PLAN, OSCAR, OXFORD EXCHANGE, Oxford Liberty, Oxford Medicare, Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2010 — Ab Internal Medicine - Internal Medicine
2012 — Ab Internal Medicine (Medical Oncology)

Education

2002-2006 — University of South Florida, Medical Education
2006-2009 — New York Presbyterian-Weill Cornell Med Ctr (Internal Medicine), Residency Training
2009-2012 — Memorial Sloan-Kettering Cancer Center (Medical Oncology), Clinical Fellowships

« Back to Results

Research Interests

The primary focus of my research is in development of new therapeutic strategies for patients with prostate, kidney and bladder cancers using novel, molecularly targeted medications. Through design and conduct of clinical trials, our team aims to improve upon the current standards of care with a focus on developing better tolerated and personalized treatments. In addition, I lead the NYU Genitourinary Oncology Tumor Registry which is a multidisciplinary effort involving clinical, basic science and translational researchers to characterize the genomic and molecular make up of genitourinary tumors and to better understand its impact on patient outcomes. Our aim is to study impact of these genetic and molecular factors on the clinical course of our patients and their response to the therapies we administer. Ultimately, our work may lay the foundation for a more individualized approach to our patients' care.

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

The impact of taxanes on the management of genitourinary cancers
Balar, Arjun V
2014 May;25(5):555-560, Anti-cancer drugs
— id: 1019322, year: 2014, vol: 25, page: 555, stat: Journal Article,

Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness
Rosenkrantz, Andrew B; Obele, Chika; Rusinek, Henry; Balar, Arjun V; Huang, William C; Deng, Fang-Ming; Ream, Justin M
2014 Aug;:45-56, Abdominal imaging
— id: 1141422, year: 2014, vol: , page: 45, stat: Journal Article,

Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer
Balar, Arjun V; Apolo, Andrea B; Ostrovnaya, Irina; Mironov, Svetlana; Iasonos, Alexia; Trout, Alisa; Regazzi, Ashley M; Garcia-Grossman, Ilana R; Gallagher, David J; Milowsky, Matthew I; Bajorin, Dean F
2013 Feb;31(6):724-730, Journal of clinical oncology
— id: 231862, year: 2013, vol: 31, page: 724, stat: Journal Article,

Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Iyer, Gopa; Al-Ahmadie, Hikmat; Schultz, Nikolaus; Hanrahan, Aphrothiti J; Ostrovnaya, Irina; Balar, Arjun V; Kim, Philip H; Lin, Oscar; Weinhold, Nils; Sander, Chris; Zabor, Emily C; Janakiraman, Manickam; Garcia-Grossman, Ilana R; Heguy, Adriana; Viale, Agnes; Bochner, Bernard H; Reuter, Victor E; Bajorin, Dean F; Milowsky, Matthew I; Taylor, Barry S; Solit, David B
2013 Jul;:3133-3140, Journal of clinical oncology
— id: 463912, year: 2013, vol: , page: 3133, stat: Journal Article,

Novel agents in invasive urothelial cancer
Balar, Arjun V; Milowsky, Matthew I
2012 Aug;10(8):504-516, Clinical advances in hematology & oncology : H&O
— id: 231872, year: 2012, vol: 10, page: 504, stat: Journal Article,

Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
Al-Ahmadie, Hikmat A; Iyer, Gopa; Janakiraman, Manickam; Lin, Oscar; Heguy, Adriana; Tickoo, Satish K; Fine, Samson W; Gopalan, Anuradha; Chen, Ying-bei; Balar, Arjun; Riches, Jamie; Bochner, Bernard; Dalbagni, Guido; Bajorin, Dean F; Reuter, Victor E; Milowsky, Matthew I; Solit, David B
2011 Jun;224(2):270-279, Journal of pathology
— id: 174631, year: 2011, vol: 224, page: 270, stat: Journal Article,

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
Balar, Arjun V; Milowsky, Matthew I
2011 Sep;108(5):699-699, BJU international
— id: 174630, year: 2011, vol: 108, page: 699, stat: Journal Article,

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy
Balar, Arjun; Bajorin, Dean F; Milowsky, Matthew I
2011 Jun;3(3):107-117, Therapeutic advances in urology
— id: 174629, year: 2011, vol: 3, page: 107, stat: Journal Article,

Delay in treatment of invasive cervical cancer due to intimate partner violence
Martino, Martin A; Balar, Arjun; Cragun, Janiel M; Hoffman, Mitchel S
2005 Nov;99(2):507-509, Gynecologic oncology
— id: 174632, year: 2005, vol: 99, page: 507, stat: Journal Article,